Stay updated on Darolutamide in Addition to ADT Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.

Latest updates to the Darolutamide in Addition to ADT Clinical Trial page
- CheckyesterdayChange DetectedThe page’s displayed software/version revision label was updated from v3.5.0 to v3.5.3, reflecting a site release rather than any change to the underlying trial record.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check40 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page history.SummaryDifference0.0%

- Check48 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check55 days agoChange DetectedThe record shows the trial status updated to Completed on 2026-02-27, replacing the previous Active, not recruiting status, and adding new Contacts/Locations, Study Status, and Recruitment Status sections on 2026-02-09.SummaryDifference0.3%

- Check69 days agoChange DetectedThe References section was removed from the study record page, and the list of cited sources is no longer displayed.SummaryDifference0.0%

- Check76 days agoChange DetectedA new history entry on 2026-02-06 adds a Study Status update with Revision: v3.4.2. The prior government funding notice (2026-01-14) has been removed (Revision: v3.4.1).SummaryDifference0.6%

Stay in the know with updates to Darolutamide in Addition to ADT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.